These findings identify PLD1 and PA as key upstream regulators of NET formation and suggest that pharmacological inhibition of PLD1 could provide a potential avenue for early intervention in NET-related diseases such as venous thrombosis. Here, PLD1 is linked to Venous thrombosis.